Automated GMP-Compliant PSC Banking In A Closed System

Gain insight into how automated adherent cell culture is reshaping the path to scalable iPSC manufacturing. Featuring perspectives from Dr. Rafal Krol (CiRA Foundation), the CliniMACS Prodigy® platform is presented in the context of advancing protocol optimization for robust, large-scale expansion of clinical-grade induced pluripotent stem cells. Key considerations include process standardization, reproducibility, and the transition from manual workflows to closed, automated systems that support consistent outcomes. Progress highlighted here reflects broader efforts to streamline cell therapy manufacturing while maintaining quality and regulatory alignment.

Access the full webinar to continue building your expertise.